Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$42.43 - $70.83 $250,379 - $417,967
5,901 New
5,901 $401,000
Q3 2021

Oct 08, 2021

SELL
$90.24 - $124.05 $182,284 - $250,581
-2,020 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$93.66 - $139.27 $189,193 - $281,325
2,020 New
2,020 $251,000
Q1 2021

Apr 14, 2021

SELL
$116.57 - $155.01 $122,748 - $163,225
-1,053 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$99.61 - $142.12 $104,889 - $149,652
1,053 New
1,053 $140,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.